Advertisement

Topics

Novel Deep Brain Stimulation in Ventral Capsule/Ventral Striatum for Methamphetamine Addiction

2017-11-27 05:47:06 | BioPortfolio

Published on BioPortfolio: 2017-11-27T05:47:06-0500

Clinical Trials [2139 Associated Clinical Trials listed on BioPortfolio]

Assessment of GVG for the Treatment of Methamphetamine Dependence

The purpose of this study is to find out if GVG can reduce drug use and determine safety and effects of GVG when used together with methamphetamine. This study involves staying in the hosp...

Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users

Addiction to methamphetamine is a serious health problem in the United States. Right now, there are no medications that a doctor can give someone to help them stop using methamphetamine. M...

Study of Medical Treatment for Methamphetamine Addiction

Currently there are no medications approved for the treatment of methamphetamine addiction. Bupropion is an antidepressant that is approved by the Food and Drug Administration (FDA) for th...

Rivastigmine as a Treatment for Methamphetamine Dependence

To study the effects of treatment with rivastigmine on craving produced by experimental administration of methamphetamine.

Paired Associative Stimulation in Methamphetamine Addiction

The investigators use paired associative stimulation (PAS) protocols to target cortico-cortical and cortico-subcortical networks to study cognitive deficits in methamphetamine addiction.

PubMed Articles [30941 Associated PubMed Articles listed on BioPortfolio]

Five-year Changes in Methamphetamine Use, Dependence, and Remission in a Community-recruited Cohort.

Investigate patterns of methamphetamine use over time, specifically factors associated with remission from dependent and harmful patterns of use; and examine drug treatment and health/support service ...

Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction: Two Case Reports.

Methamphetamine (MA) addiction is one of the most prevalent socioeconomic and health problems worldwide. In recent years, deep brain stimulation (DBS) has increasingly been used for the treatment of a...

Gender does not matter: Add-on repetitive transcranial magnetic stimulation treatment for female methamphetamine dependents.

Transcranial magnetic stimulation (TMS) targeting prefrontal cortex reduces craving in different types of drug addiction. However, most studies failed to elucidate the potential gender discrepancies f...

Methamphetamine use causes cognitive impairment and altered decision-making.

Methamphetamine is a widely abused psychostimulant. It reverses transport through the dopamine transporter, thereby increasing the extracellular level of dopamine in the brain, which is associated wit...

Surgical Treatment of Bilateral Lung Cancers: Long-Term Outcomes and Prognostic Factors.

 Bilateral lung neoplasms are becoming more common, but distinguishing two primary lung cancers from metastatic disease can be difficult and only long-term follow-up after treatment can disclose the...

Medical and Biotech [MESH] Definitions

Surgical insertion of cylindric hydraulic devices for the treatment of organic ERECTILE DYSFUNCTION.

Surgical insertion of an appliance for the replacement of areas of the maxilla, mandible, and face. When only portions of the mandible are replaced, it is referred to as MANDIBULAR PROSTHESIS IMPLANTATION.

A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.

Surgical insertion of an electronic hearing device (AUDITORY BRAIN STEM IMPLANTS) with electrodes to the cochlea nucleus in the BRAIN STEM rather than to the inner ear as in COCHLEAR IMPLANTATION.

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

More From BioPortfolio on "Novel Deep Brain Stimulation in Ventral Capsule/Ventral Striatum for Methamphetamine Addiction"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial